FIGS, Inc. (NYSE:FIGS – Get Free Report) was up 9.9% during mid-day trading on Thursday after the company announced better than expected quarterly earnings. The company traded as high as $11.99 and last traded at $12.0440. Approximately 2,536,940 shares were traded during trading, a decline of 1% from the average daily volume of 2,561,678 shares. The stock had previously closed at $10.96.
The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.02 by $0.08. The business had revenue of $201.90 million during the quarter, compared to analysts’ expectations of $165.33 million. FIGS had a return on equity of 8.62% and a net margin of 5.43%.The company’s revenue for the quarter was up 33.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.01 EPS.
FIGS News Summary
Here are the key news stories impacting FIGS this week:
- Positive Sentiment: Q4 earnings beat — FIGS reported $0.10 EPS vs. $0.02 consensus and revenue of $201.9M (up 33% YoY), signaling solid top-line momentum and margin expansion. Article Title
- Positive Sentiment: Aggressive FY2026 revenue guide — management is targeting roughly $694M–$707M (around a $700M target cited publicly), well above Street consensus (~$625.6M), and flagged international expansion and margin improvement as priorities. That guidance materially raises growth expectations. Article Title
- Positive Sentiment: Analyst upgrade — KeyCorp moved FIGS from sector weight to overweight with a $17 price target, providing third‑party validation of the company’s growth trajectory. Article Title
- Neutral Sentiment: Telsey raised its price target from $9 to $15 and set a “market perform” rating — upgrade in target, but PT sits slightly below the current share price. Article Title
- Neutral Sentiment: BTIG reaffirmed a “buy” rating with a $15 target — keeps buy conviction but target is not above the current price, limiting near-term upside from that shop. Article Title
- Neutral Sentiment: Conference call and analyst write-ups published — transcripts and call highlights provide detail on Olympic partnership, international rollout and margin levers for investors doing deeper diligence. Article Title
- Negative Sentiment: Valuation and mixed price-targets risk — FIGS trades with a high P/E and recently hit a 12‑month high, leaving shares vulnerable to profit-taking; several widely cited targets (~$15) sit at or below the current price. Article Title
Wall Street Analysts Forecast Growth
Get Our Latest Research Report on FIGS
Insiders Place Their Bets
In other FIGS news, CFO Sarah Oughtred sold 22,690 shares of the stock in a transaction dated Thursday, February 5th. The shares were sold at an average price of $10.56, for a total value of $239,606.40. Following the completion of the sale, the chief financial officer owned 821,500 shares in the company, valued at approximately $8,675,040. This represents a 2.69% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Heather L. Hasson sold 22,874 shares of the business’s stock in a transaction that occurred on Thursday, February 5th. The stock was sold at an average price of $10.56, for a total value of $241,549.44. Following the transaction, the insider owned 1,251,967 shares in the company, valued at approximately $13,220,771.52. This represents a 1.79% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 105,813 shares of company stock valued at $1,168,051 in the last 90 days. 29.44% of the stock is owned by insiders.
Hedge Funds Weigh In On FIGS
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Marshall Wace LLP increased its stake in shares of FIGS by 66.2% in the 4th quarter. Marshall Wace LLP now owns 4,297,868 shares of the company’s stock worth $48,824,000 after acquiring an additional 1,712,610 shares during the last quarter. Bamco Inc. NY boosted its position in shares of FIGS by 2.2% during the 2nd quarter. Bamco Inc. NY now owns 59,974,407 shares of the company’s stock valued at $338,256,000 after acquiring an additional 1,302,823 shares during the last quarter. BNP Paribas Financial Markets grew its holdings in shares of FIGS by 2,139.7% in the second quarter. BNP Paribas Financial Markets now owns 1,307,468 shares of the company’s stock valued at $7,374,000 after purchasing an additional 1,249,091 shares during the period. Ameriprise Financial Inc. increased its position in FIGS by 9.0% during the second quarter. Ameriprise Financial Inc. now owns 13,936,468 shares of the company’s stock worth $78,602,000 after purchasing an additional 1,144,962 shares during the last quarter. Finally, Squarepoint Ops LLC increased its position in FIGS by 940.7% during the second quarter. Squarepoint Ops LLC now owns 924,092 shares of the company’s stock worth $5,212,000 after purchasing an additional 835,300 shares during the last quarter. Institutional investors and hedge funds own 92.21% of the company’s stock.
FIGS Price Performance
The company has a market capitalization of $2.54 billion, a PE ratio of 81.24 and a beta of 1.29. The business’s 50 day simple moving average is $11.39 and its 200 day simple moving average is $9.35.
FIGS Company Profile
FIGS, Inc operates as a direct-to-consumer designer and retailer of medical apparel and accessories. The company offers a range of products tailored to the needs of healthcare professionals, including scrub sets, lab coats, tops, bottoms, outerwear, footwear, and performance fabrics designed for comfort, durability, and antimicrobial protection. Through its e-commerce platform and a growing network of retail stores, FIGS provides customizable uniforms and accessories with a focus on innovative materials and functional design features such as four-way stretch fabrics, moisture-wicking technology, and multiple secure pockets.
Founded in 2013 by Heather Hasson and Trina Spear, FIGS set out to disrupt the traditional medical uniform market by emphasizing both form and function.
Featured Articles
- Five stocks we like better than FIGS
- 3 Signs You May Want to Switch Financial Advisors
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- Your name isn’t on our protected list yet
- Elon Musk already made me a “wealthy man”
- MAJOR BUY ALERT: Mar-a-Lago/Trump/Elon
Receive News & Ratings for FIGS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FIGS and related companies with MarketBeat.com's FREE daily email newsletter.
